<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30369653</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0100-3984</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>51</Volume>                    <Issue>5</Issue>                    <PubDate>                        <MedlineDate>2018 Sep-Oct</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>Radiologia brasileira</Title>                <ISOAbbreviation>Radiol Bras</ISOAbbreviation>            </Journal>            <ArticleTitle>Radiation-induced angiosarcoma of the breast: a retrospective analysis of 15 years' experience at an oncology center.</ArticleTitle>            <Pagination>                <MedlinePgn>281-286</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1590/0100-3984.2017.0129</ELocationID>            <Abstract>                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To characterize a population of patients with radiation-induced angiosarcoma (RIAS) of the breast treated at an oncology center, focusing mainly on the imaging features, although also on the clinical presentation, diagnosis, and management.</AbstractText>                <AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">We performed a retrospective review of patients with histologically proven angiosarcoma of the breast or chest wall, all of whom received radiotherapy, after conservative or radical breast surgery, between 2000 and 2015.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Eleven patients met the inclusion criteria. The median age at the time of diagnosis of RIAS of the breast was 71.5 years (range, 58-87 years), and the median latency period was 8.9 years (range, 4-27 years). The rate of local recurrence was 54.4%, RIAS recurring after a median period of 10 months (range, 3-18 months), and distant metastases occurred in three patients (27.3%). All of the tumors were accompanied by skin changes, and a palpable mass was seen in four. Most of the imaging findings were nonspecific. Six patients underwent magnetic resonance imaging, which revealed pronounced skin enhancement in all six. Ultrasound-guided core needle biopsies were negative in three of the eight patients.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">RIAS of the breast is a rare but recognized complication of radiotherapy for breast carcinoma, with a poor prognosis and high recurrence rate, which requires a high index of suspicion for a prompt diagnosis.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Alves</LastName>                    <ForeName>Ines</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Hospital Central do Funchal, Funchal, Portugal.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Marques</LastName>                    <ForeName>José Carlos</ForeName>                    <Initials>JC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Brazil</Country>            <MedlineTA>Radiol Bras</MedlineTA>            <NlmUniqueID>1305000</NlmUniqueID>            <ISSNLinking>0100-3984</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Clin Pract Oncol. 2008 Dec;5(12):727-36</RefSource>                <PMID Version="1">18936792</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2007 Mar;242(3):725-34</RefSource>                <PMID Version="1">17325063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiographics. 2007 Oct;27 Suppl 1:S125-30</RefSource>                <PMID Version="1">18180222</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2012;17(3):405-18</RefSource>                <PMID Version="1">22334455</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2003 Apr 15;97(8):1832-40</RefSource>                <PMID Version="1">12673708</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2014 Jul;50(10):1779-88</RefSource>                <PMID Version="1">24731859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gland Surg. 2014 Feb;3(1):28-34</RefSource>                <PMID Version="1">25083491</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2007 Apr;18(4):801</RefSource>                <PMID Version="1">17229767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2007 Sep;105(1):81-5</RefSource>                <PMID Version="1">17115110</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1980 Jul 15;46(2):368-71</RefSource>                <PMID Version="1">7190060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2005 Aug 15;104(4):856-63</RefSource>                <PMID Version="1">15981282</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2012 Nov;19(12):3801-8</RefSource>                <PMID Version="1">22890593</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2012 Aug;19(8):2700-6</RefSource>                <PMID Version="1">22466664</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1231-7</RefSource>                <PMID Version="1">11955733</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Magn Reson Imaging. 2015 Sep;42(3):763-70</RefSource>                <PMID Version="1">25504856</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ecancermedicalscience. 2014 Feb 17;8:402</RefSource>                <PMID Version="1">24605134</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2013 Apr;20(4):1267-74</RefSource>                <PMID Version="1">23224828</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2013 Jul-Aug;19(4):435-6</RefSource>                <PMID Version="1">23721487</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Rep Pract Oncol Radiother. 2013 Aug 23;19(1):37-46</RefSource>                <PMID Version="1">24936318</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <OtherAbstract Type="Publisher" Language="por">            <AbstractText Label="Objetivo" NlmCategory="UNASSIGNED">Caracterizar uma população de pacientes com angiossarcoma da mama induzido por radioterapia em um instituto de oncologia, com foco principalmente nas características de imagem, mas também na apresentação clínica, diagnóstico e gerenciamento.</AbstractText>            <AbstractText Label="Materiais e Métodos" NlmCategory="UNASSIGNED">Efetuamos análise retrospectiva, entre 2000 e 2015, de pacientes com angiossarcoma da mama ou parede torácica histologicamente comprovado que foram previamente irradiadas após cirurgia mamária, conservadora ou radical.</AbstractText>            <AbstractText Label="Resultados" NlmCategory="UNASSIGNED">Onze pacientes preencheram os critérios de inclusão. A mediana da idade na ocasião do diagnóstico de angiossarcoma da mama induzido por radioterapia foi 71,5 anos (variação: 58-87 anos) e o período médio de latência foi 8,9 anos (variação: 4-27 anos). A taxa de recorrência local foi 54,4%, após mediana de 10 meses (variação: 3-18 meses), e metástases a distância ocorreram em três pacientes (27,3%). Todos os tumores apresentaram alterações na pele, e massa palpável observou-se em quatro. Os achados de imagens foram globalmente inespecíficos. Os seis paciente que realizaram ressonância magnética revelaram aumento de captação de contraste cutâneo. As biópsias ecoguiadas foram negativas em três de oito pacientes.</AbstractText>            <AbstractText Label="Conclusão" NlmCategory="UNASSIGNED">Angiossarcoma da mama induzido por radioterapia é complicação rara, mas conhecida, da radioterapia para câncer da mama, com mau prognóstico e alta taxa de recorrência, sendo necessário elevado índice de suspeição para seu diagnóstico imediato.</AbstractText>        </OtherAbstract>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Hemangiosarcoma/diagnosis</Keyword>            <Keyword MajorTopicYN="N">Neoplasms, radiation-induced</Keyword>            <Keyword MajorTopicYN="N">Radiotherapy</Keyword>            <Keyword MajorTopicYN="N">Tertiary care centers</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30369653</ArticleId>            <ArticleId IdType="doi">10.1590/0100-3984.2017.0129</ArticleId>            <ArticleId IdType="pmc">PMC6198847</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>